4
Changes in Ownership
HALOZYME THERAPEUTICS, INC. Filed Acc 0001179110-21-001809
Options or other derivatives
- SVP, Chief Technical Officer acquired 36,855 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
LaBarre Michael J. · SVP, Chief Technical Officer
Table II: Derivative
2 lines| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2021-02-15 | Grant or award : show line 1 in the form Option to Purchase Common Stock | +23,311 | $49.84 | 2031-02-15 | 23,311 | 23,311 | D |
| 2021-02-15 | Grant or award : show line 2 in the form Restricted Stock Units | +13,544 | $0.00 | 13,544 | 13,544 | D |
Loading xslF345X03/edgar.xml…